✦ LIBER ✦

Aztreonam-new development in treatment of gram negative infections

Book ID: 112833026
Publisher: Springer-Verlag
Year: 1990
Tongue: English
Weight: 60 KB
Volume: 57
Category: Article
ISSN: 0019-5456
DOI: 10.1007/bf02722082

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of gram-negative infections wi

Treatment of gram-negative infections with aztreonam

✍ William J. Simons; Terrence J. Lee 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 415 KB

Treatment of neonatal gram-negative infe

Treatment of neonatal gram-negative infections with aztreonam

✍ Ezzat Micheal; Hani Sukkar; Atef Dessouki 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 242 KB

Aztreonam: Worldwide overview of the tre

Aztreonam: Worldwide overview of the treatment of patients with gram-negative infections

✍ Sharon A. Henry; Cecil B. Bendush 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 886 KB

Randomized comparison of aztreonam and c

Randomized comparison of aztreonam and cefuroxime in gram-negative upper urinary tract infections

✍ G. Friman; O. Cars; I. Odenholt-Tornqvist; C. Rydén; E. Bäck; H. Fredlund; H. Be 📂 Article 📅 1989 🏛 Springer-Verlag 🌐 English ⚖ 932 KB

New treatment modalities for serious Gra

New treatment modalities for serious Gram-negative bacterial infections

✍ VERHOEF, J 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 882 KB

Aztreonam vs. cefotaxime in the treatmen

Aztreonam vs. cefotaxime in the treatment of gram-negative spontaneous peritonitis in cirrhotic patients

✍ Javier Ariza; Xavier Xiol; Maria Esteve; Fernando Fernández Bañeres; Josefina Li 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 825 KB

Aztreonam and cefotaxime were compared in 44 cirrhotic patients who had 52 episodes of gram-negative spontaneous peritonitis. Patients were randomized into two therapeutic groups of similar characteristics. Group A (28 episodes) received 0.5 gm of aztreonam every 8 hr, and group B (24 episodes) rece